Profil
Steven Hamburger worked as the VP, Head-Regulatory Affairs & Quality Assurance at Tarveda Therapeutics, Inc. from 2018 to 2019.
He then served as the Vice President & Head-Regulatory Affairs at Checkmate Pharmaceuticals, Inc. He also worked in Clinical Regulatory Affairs at FerGene, Inc. Currently, he is the Senior VP-Regulatory Affairs & Quality Assurance at Oncternal Therapeutics, Inc. from 2021 to 2023.
Dr. Hamburger holds a graduate degree from Butler University, an undergraduate degree from the University of Iowa, and a doctorate degree from The Indiana University School of Medicine.
Anciens postes connus de Steven Hamburger
| Sociétés | Poste | Fin |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | General Counsel | 02/03/2023 |
| CHECKMATE PHARMACEUTICALS, INC. | General Counsel | 01/11/2020 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | General Counsel | 01/10/2019 |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | General Counsel | - |
Formation de Steven Hamburger
| Butler University | Graduate Degree |
| University of Iowa | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
